AbbVie (CHIX:4ABD) Long-Term Debt : €57,625 Mil (As of Dec. 2024)

View and export this data going back to 2023. Start your Free Trial

What is AbbVie Long-Term Debt?

AbbVie's Long-Term Debt for the quarter that ended in Dec. 2024 was €57,625 Mil.

AbbVie's quarterly Long-Term Debt declined from Jun. 2024 (€53,927 Mil) to Sep. 2024 (€52,717 Mil) but then increased from Sep. 2024 (€52,717 Mil) to Dec. 2024 (€57,625 Mil).

AbbVie's annual Long-Term Debt declined from Dec. 2022 (€55,823 Mil) to Dec. 2023 (€47,862 Mil) but then increased from Dec. 2023 (€47,862 Mil) to Dec. 2024 (€57,625 Mil).

AbbVie Long-Term Debt Historical Data

The historical data trend for AbbVie's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AbbVie Long-Term Debt Chart

AbbVie Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Long-Term Debt

Get a 7-Day Free Trial

63,749.39

56,807.27

55,823.44

47,861.90

57,624.70

AbbVie Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Long-Term Debt	Get a 7-Day Free Trial															47,861.90	58,700.60	53,926.59	52,716.61	57,624.70

AbbVie (CHIX:4ABd) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

AbbVie Long-Term Debt Related Terms

Thank you for viewing the detailed overview of AbbVie's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

AbbVie Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AbbVie Inc (CHIX:4ABd) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

ABBV:USA ABBV:Mexico 1ABBV:Italy 0QCV:UK 4AB:Germany ABBVCL:Chile ABBV:Canada ABBV34:Brazil 4AB:Bulgaria ABBV:Austria ABBV:Argentina

Address

1 North Waukegan Road, North Chicago, IL, USA, 60064-6400

Website

https://www.abbvie.com

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).

AbbVie Headlines

No Headlines